Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

The Second Affiliated Hospital Of Kunming Medical University

Clinical trials sponsored by The Second Affiliated Hospital Of Kunming Medical University, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New Triple-Drug strategy aims to boost remission in Hard-to-Treat leukemia Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 2

New Triple-Drug strategy aims to boost remission in Hard-to-Treat leukemia

Disease control Recruiting now

This phase 3 trial tests whether combining the targeted drug venetoclax with either a short course of decitabine or a modified DA regimen (daunorubicin and cytarabine) works better than the standard 3+7 DA regimen for adults newly diagnosed with acute myeloid leukemia. About 291 …

Phase 3 • Sponsor: The Second Affiliated Hospital of Kunming Medical University • Aim: Disease control

Last updated Jul 22, 2026 00:00 UTC